These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23740900)

  • 1. Dual receptor T cells mediate pathologic alloreactivity in patients with acute graft-versus-host disease.
    Morris GP; Uy GL; Donermeyer D; Dipersio JF; Allen PM
    Sci Transl Med; 2013 Jun; 5(188):188ra74. PubMed ID: 23740900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the Whole CDR3 T Cell Receptor Repertoire after Hematopoietic Stem Cell Transplantation in 2 Clinical Cohorts.
    Shah O; Tamaresis JS; Kenyon LJ; Xu L; Zheng P; Gupta P; Rangarajan K; Lee S; Spellman S; Nikiforow S; Zehnder J; Meyer EH
    Biol Blood Marrow Transplant; 2020 Jun; 26(6):1050-1070. PubMed ID: 32081787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The highly alloreactive nature of dual TCR T cells.
    Balakrishnan A; Morris GP
    Curr Opin Organ Transplant; 2016 Feb; 21(1):22-8. PubMed ID: 26555233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of alloanergy in human donor T cells without loss of pathogen or tumor immunity.
    Davies JK; Yuk D; Nadler LM; Guinan EC
    Transplantation; 2008 Sep; 86(6):854-64. PubMed ID: 18813111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation-associated phenotype of CD3 T cells in acute graft-versus-host disease.
    Paz Morante M; Briones J; Canto E; Sabzevari H; Martino R; Sierra J; Rodriguez-Sanchez JL; Vidal S
    Clin Exp Immunol; 2006 Jul; 145(1):36-43. PubMed ID: 16792671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-target antigens and T-cell receptor diversity of activated T cells invading the skin during acute graft-versus-host disease.
    Gaschet J; Treviño MA; Cherel M; Vivien R; Garcia-Sahuquillo A; Hallet MM; Bonneville M; Harrousseau JL; Bragado R; Milpied N; Vié H
    Blood; 1996 Mar; 87(6):2345-53. PubMed ID: 8630397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting edge: Highly alloreactive dual TCR T cells play a dominant role in graft-versus-host disease.
    Morris GP; Allen PM
    J Immunol; 2009 Jun; 182(11):6639-43. PubMed ID: 19454656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ex vivo toll-like receptor 7 tolerance induction in donor lymphocytes prevents murine acute graft-versus-host disease.
    Zogas N; Karponi G; Iordanidis F; Malasidis S; Paraskevas V; Papadopoulou A; Scouras ZG; Anagnostopoulos A; Yannaki E
    Cytotherapy; 2018 Jan; 20(1):149-164. PubMed ID: 29150086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation.
    Sheng L; Mu Q; Wu X; Yang S; Zhu H; Wang J; Lai Y; Wu H; Sun Y; Hu Y; Fu H; Wang Y; Xu K; Sun Y; Zhang Y; Zhang P; Zhou M; Lai B; Xu Z; Gao M; Zhang Y; Ouyang G
    Front Immunol; 2020; 11():1534. PubMed ID: 32849519
    [No Abstract]   [Full Text] [Related]  

  • 10. Alloimmune T cells in transplantation.
    DeWolf S; Sykes M
    J Clin Invest; 2017 Jun; 127(7):2473-2481. PubMed ID: 28628037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation.
    Shah NN; Baird K; Delbrook CP; Fleisher TA; Kohler ME; Rampertaap S; Lemberg K; Hurley CK; Kleiner DE; Merchant MS; Pittaluga S; Sabatino M; Stroncek DF; Wayne AS; Zhang H; Fry TJ; Mackall CL
    Blood; 2015 Jan; 125(5):784-92. PubMed ID: 25452614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD3+/Tregs ratio in donor grafts is linked to acute graft-versus-host disease and immunologic recovery after allogeneic peripheral blood stem cell transplantation.
    Pastore D; Delia M; Mestice A; Carluccio P; Perrone T; Gaudio F; Curci P; Rossi AR; Ricco A; Specchia G
    Biol Blood Marrow Transplant; 2012 Jun; 18(6):887-93. PubMed ID: 22062803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional structure discrepancy between HLA alleles for effective prediction of aGVHD severity and optimal selection of recipient-donor pairs: a proof-of-concept study.
    Han H; Yuan F; Sun Y; Liu J; Liu S; Luo Y; Liang F; Liu N; Long J; Zhao X; Kong F; Xi Y
    Oncotarget; 2015 Nov; 6(37):40337-59. PubMed ID: 26498683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study.
    van Balen P; Jedema I; van Loenen MM; de Boer R; van Egmond HM; Hagedoorn RS; Hoogstaten C; Veld SAJ; Hageman L; van Liempt PAG; Zwaginga JJ; Meij P; Veelken H; Falkenburg JHF; Heemskerk MHM
    Front Immunol; 2020; 11():1804. PubMed ID: 32973756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superagonistic CD28 stimulation of allogeneic T cells protects from acute graft-versus-host disease.
    Beyersdorf N; Ding X; Hünig T; Kerkau T
    Blood; 2009 Nov; 114(20):4575-82. PubMed ID: 19721011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collateral damage of nonhematopoietic tissue by hematopoiesis-specific T cells results in graft-versus-host disease during an ongoing profound graft-versus-leukemia reaction.
    van der Zouwen B; Kruisselbrink AB; Frederik Falkenburg JH; Jedema I
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):760-9. PubMed ID: 24607556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch pathway plays a novel and critical role in regulating responses of T and antigen-presenting cells in aGVHD.
    Luo X; Xu L; Li Y; Tan H
    Cell Biol Toxicol; 2017 Apr; 33(2):169-181. PubMed ID: 27770236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II.
    van Balen P; van Bergen CAM; van Luxemburg-Heijs SAP; de Klerk W; van Egmond EHM; Veld SAJ; Halkes CJM; Zwaginga JJ; Griffioen M; Jedema I; Falkenburg JHF
    Front Immunol; 2018; 9():3016. PubMed ID: 30619360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute graft-vs-host disease: pathobiology and management.
    Goker H; Haznedaroglu IC; Chao NJ
    Exp Hematol; 2001 Mar; 29(3):259-77. PubMed ID: 11274753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.